CANDACE BARKER: Open Payments
NPI 1306216825 · ANNISTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,729 in 189 payments from 44 companies in 2025. Trend: 2023 $3,338 · 2024 $3,443 · 2025 $4,729
Food & beverage: $3,841Honoraria: $788Education: $100
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation | 6 | $1,003 |
| Novartis Pharmaceuticals Corporation | 25 | $476 |
| AstraZeneca Pharmaceuticals LP | 21 | $438 |
| Janssen Biotech, Inc. | 17 | $395 |
| PFIZER INC. | 18 | $241 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $149 |
| Stemline Therapeutics Inc. | 4 | $140 |
| BeOne Medicines USA, Inc. | 8 | $137 |
| Pharmacosmos Therapeutics Inc. | 8 | $136 |
| GENZYME CORPORATION | 4 | $123 |
Products named: BESREMI, IMFINZI, KISQALI, ERLEADA, Orserdu, MONOFERRIC, BRUKINSA, AYVAKIT.
Industry payments across AL — which companies pay providers there.
